Facebook Pixel Code

Unjha Formulations Share Price

NSE
BSE

UNJHA FORMULATIONS

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Unjha Formulations along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹24.99
0.44₹ 0.11
As on Sep 17, 2025, 10:41 AM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Unjha Formulations Price Performance

Today's LowToday's High
₹24.21₹25.75
₹24.99
52 Weeks' Low52 Weeks' High
₹19.99₹39.00
₹24.99
Open Price
₹24.75
Prev. Close
₹24.88
Volume
11,329

Over the last 5 years, the share price of Unjha Formulations has gained 25.84% CAGR. Over the past year, the corresponding return has been -19.23%.

Unjha Formulations’s current P/E of 115.69x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Unjha Formulations Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Unjha Formulations
-0.21.264.1217.71-19.2340.5525.84
Sun Pharmaceutical Industries
0.94-1.45-2.44-5.71-13.7822.5325.74
Divi's Laboratories
1.54-0.7-6.33812.2619.1513.78
Cipla
-0.82-0.863.163.88-7.1914.4415.58
Torrent Pharmaceuticals
-1.87-3.488.4215.222.1533.5819.96
Dr. Reddy's Laboratories
0.293.49-0.8313.69-1.3716.856.26
Mankind Pharma
-1.224.339.5518.645.0321.8612.59
Zydus Lifesciences
-0.824.497.515.4-7.1642.0421.2
Lupin
33.434.812.31-10.2946.9814.44
Abbott India
-0.31-4.38-1.93.418.0621.5213.67
Alkem Laboratories
2.882.3413.7413.65-11.9919.0314.03
Aurobindo Pharma
4.380.59-1.18-1.48-29.3628.256.21
Glenmark Pharmaceuticals
-3.733.9324.0843.419.7676.9133.04
Laurus Labs
0.424.0636.3154.8679.6221.0626.22
Biocon
-0.99-1.062.217.92-4.037.5-4.01
Anthem Biosciences
2.584.4614.5314.5314.534.632.75
GlaxoSmithKline Pharmaceuticals
-2.62-1.08-15.162.48-1.4525.059.38
Cohance Lifesciences
-0.39.77-0.58-13.11-14.6128.9820.79
Ipca Laboratories
0.68-4.46-2.50.56-9.1715.554.26
Gland Pharma
5.081.4414.528.778.28-3.781.9

Over the last one year, Unjha Formulations has declined 19.23% compared to peers like Sun Pharmaceutical Industries (-13.78%), Divi's Laboratories (12.26%), Cipla (-7.19%). From a 5 year perspective, Unjha Formulations has outperformed peers relative to Sun Pharmaceutical Industries (25.74%) and Divi's Laboratories (13.78%).

Unjha Formulations Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Unjha Formulations Stock Technicals

Moving Average

DaySMAEMA
525.0825.1
1025.0425.06
2024.9924.98
5024.7224.69
10024.0924.58
20025.4224.78

Unjha Formulations Share Holding Pattern

In the latest quarter, Unjha Formulations remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 63.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Unjha Formulations Corporate Actions

Date Time
Announcement
Sep 05, 2025, 8:10 PM ISTUnjha Formulatio - Submissions Of XML File For Financial Statement I.E. Balance Sheet , P&L Accounts And Cash Flow Statement
Aug 14, 2025, 12:42 AM ISTUnjha Formulatio - Filing Of Distribution Schedule
Aug 14, 2025, 12:32 AM ISTUnjha Formulatio - Cash Flow Statement For The Year Ended 31.03.2025
Aug 14, 2025, 12:29 AM ISTUnjha Formulatio - Intimation Under Regulation 30 Read With Part A Of The Schedule III Of SEBI (Listing Obligations And Discl
Aug 14, 2025, 12:25 AM ISTUnjha Formulatio - Regulation 44(3) Of The SEBI (Listing Obligation And Disclosure Requirements) I.E. Voting Results

About Unjha Formulations

Unjha Formulations Ltd. is a Public Limited Listed company incorporated on 02/09/1994 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1994PLC022932 and registration number is 022932. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 13.86 Cr. and Equity Capital is Rs. 4.48 Cr. for the Year ended 31/03/2025.

Management

  • Mrs. Jashodaben S Patel
    Chairman
  • Mrs. Krutiben M Patel
    Managing Director
  • Ms. Esha M Patel
    Director
  • Mr. Hashmukh S Darji
    Director
  • Mr. Jitendra P Lambachiya
    Director
  • Mr. Mustufa Najamuddin Jodhpurwala
    Director

FAQs on Unjha Formulations Share Price

What is the share price of Unjha Formulations?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Unjha Formulations is ₹24.99 as on Sep 17, 2025.

What kind of stock is Unjha Formulations?

The Unjha Formulations is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Unjha Formulations?

The market cap of Unjha Formulations is ₹11.20 Cr as on Sep 17, 2025.

What are today's High and Low prices of Unjha Formulations?

Today’s highest and lowest price of Unjha Formulations are ₹25.75 and ₹24.21.

What are the 52 Week High and 52 Week Low of Unjha Formulations?

The 52-week high/low is the highest and lowest price at which Unjha Formulations stock has traded in the past 52-week or nearly a year. The 52-week high of Unjha Formulations is ₹39.00 and 52-week low of Unjha Formulations is ₹19.99 as on Sep 17, 2025.

How has the Unjha Formulations performed historically in terms of returns?

The Unjha Formulations has shown returns of 0.44% over the past day, 1.26% for the past month, 4.12% over 3 months, -19.23% over 1 year, 40.55% across 3 years, and 25.84% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Unjha Formulations?

P/E ratio of and PB ratio of Unjha Formulations are 115.69 and 3.57 on Sep 17, 2025. While the company gives a dividend yield of 0.00 per annum.

icon
Market Data